BioMicro to exploit Myriad's microfluidic method:
This article was originally published in Clinica
Executive Summary
Myriad Genetics (Salt Lake City, Utah) has been awarded a US patent for its microfluidic passive fluid dynamics technology and has licensed the patent rights to BioMicro Systems. Unlike conventional active systems that require sound, electricity or mechanical valves to control the movement of fluid, passive fluid control devices use constrictions in the microchannels to regulate the flow of liquids in microfluidic devices. BioMicro says the technology can be used to develop diagnostic products as well as products for use in genomic and drug discovery research.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.